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Purpose: We have investigated the effect of University of Wisconsin (UW) solution at 
different emperatures on endothelial and smooth muscle cell function of the human 
saphenous vein to define the efficacy of UW solution as a preservation solution for 
saphenous vein conduits. 
Methods: Saphenous vein segments from 38 patients undergoing coronary artery bypass 
surgery were examined with an isolated organ bath technique to monitor changes in 
vessel reactivity. 
Results: Endothelial-dependent relaxations to acetylcholine were attenuated after incuba- 
tion in UW solution at both 4 ° C and 28 ° C (p < 0.05, n = 10). In contrast, relaxations 
to sodium nitroprusside were unchanged after incubation in UW solution at both 
temperatures (n = 8). The responses to 90 mmol/L KCI were increased at both 4 ° C and 
28 ° C, respectively. Tyrode's: 27.2% -+ 3.1% and 23.8% "4- 3.0%, UW: 64.7% - 8.0% and 
73.1% + 11% (p < 0.001). In addition, the responses to 5-HT were enhanced at 4 ° C and 
28 ° C (p < 0.05). In contrast, responses to noradrenaline were enhanced only at 28 ° C 
compared with the responses after incubations in Tyrode's olution (p < 0.05, n -- 6). 
Furthermore U46619 (0.3 nmol/L to 1 nmol/L) responses were augmented at4 ° C (p < 
0.05, n = 7). The potency (pD2) values for each agonist were not significantly different 
after incubations in UW solution. 
Conclusions: We conclude that UW solution produces attenuation of acetylcholine r lax- 
ations and temperature-dependent increased reactivity of smooth-muscle c ll function in 
the isolated human saphenous vein. These studies document the complex interactions 
brought about by UW solution on the different components of the vascular wall that 
need to be elucidated further if this solution is to attain a place in vascular preservation. 
(J Vasc Surg 1997;25:713-21.) 
In the last decade research as shown that the 
saphenous vein performs adynamic role in regulating 
and controlling its function. Saphenous vein grafts 
are capable of contraction and relaxation, and a wide 
range of vascular mechanisms may act to guard 
against early and late graft occlusion. 1,2 The response 
of the saphenous vein to various vasoactive mediators 
will depend on the receptor profile on the endothe- 
lium and smooth muscle cells. In this context preser- 
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vation of saphenous vein endothelial and smooth 
muscle cell function is thought o be of  paramount 
importance in coronary artery bypass urgery. 
The integrity and function of the grafted vessel, 
in particular the biologic integrity of the endothe- 
lium, is influenced by various factors. The technique 
of dissection, the type of distending solution and 
distending pressure, and the composition and tem- 
perature of  storage solution are important factors for 
optimum endothelial preservation. The influence of 
different ypes of storage solutions and storage tem- 
peratures has been extensively studied. These studies 
have found that the use of normal saline solution 
causes substantial endothelial damage, 3-s whereas 
blood 6 and various balanced salt solutions 7 or cell 
culture media 8 produce good endothelial preserva- 
tion. 
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JOURNAL OF VASCULAR SURGERY 
714 Anastasiou et al. April 1997 
-10 
5 
-25 
A 
Aeetylcholine (log M) 
o~ 
-15, 
-20 - 
Acetylcholine (leg M) 
-5 -10 -9 -8 -7 -6 -5 
I 5 I | I I I 
0 J 
-5.  
-10'  
-15' 
B 
Fig. 1. A, Effect of temperature of LrVV solution on endothelium-dependent r laxations to 
acetylcholine (1 nmol/L to 1 mmol/L) at both 4 ° C (open circles) and B, 28 ° C (open squares) 
compared with Tyrode's olution at 4 ° C (closed circles) and Tyrode's olution at 28 ° C (closed 
squares). Relaxations to acetylcholine were attenuated after incubation i  UW solution at both 
temperatures (p < 0.05, n = 10). 
The University of Wisconsin (UW) solution has 
proven to be efficacious on preserving cell functions 
of solid organs 9J° and parenchymal tissues) 1-~3 In- 
terest in the quality of organ preservation has con- 
centrated recently on "nonparenchymal cells," for 
example, endothelial cells) 4-16 The superiority of the 
UW solution over normal saline solution, urocolins, 
and balanced salt solutions for the preservation of 
endothelial ultrastructure and cell survival has been 
shown in human umbilical vein endothelial cells 16,17 
and for the coronary endothelium. 18,19 On the other 
hand, these studies have also shown that UW solu- 
tion produces temperature-dependent ndothelial 
dysfunction i  the isolated rat heart. The influence of 
storage temperature on vein graft preservation has 
been studied extensively. 2°,2~ Although the results of 
these investigations did not all support the use of 
normothermic or room temperature storage, the 
overall view was that preparation and storage with 
solutions at 4 ° C produce substantial endothelial dis- 
ruption. Thus it appears that complex interactions 
exist between preservation solutions and tempera- 
ture. 
The optimal method for preservation of acute 
and chronic vein graft function has not been estab- 
lished. In view of the magnitude of the clinical prob- 
lem, continued intensive study of the basic science of 
the saphenous vein and its interactions with the corn- 
position of preservation solutions is needed. The 
effect of UW solution on the functional integrity of 
the saphenous vein endothelium and smooth muscle 
cells has not been studied. We have therefore xam- 
ined the interaction between UW solution and tem- 
perature on the vascular eactivity of the saphenous 
vein to define the efficacy of  UW solution as a pres- 
ervation solution for saphenous vein conduits. 
METHODS 
Tissue preparation. Specimens of human un- 
distended saphenous vein were obtained as excess to 
requirement from 38 patients undergoing coronary 
artery bypass surgery. Informed consent was ob- 
tained from each patient, and the study was approved 
by the Harefield Hospital Ethical Committee. At the 
time of the study none of  the patients was taking 
drugs known to affect vessel function in our model, 
and therefore potential systemic pharmacologic ef- 
fects on experiments could be ignored. The vessels 
were immediately placed in modified Tyrode's olu- 
tion (28 ° C) of the following composition (in milli- 
molars): NaC1 136.9, NaHCO 3 11.9, KCI 2.7, 
NaH2PO 4 0.4, MgC1 2.5, CaCI 2 2.5, glucose 11.1, 
and disodium ethylenediamine tetraacetic acid 0.04. 
The blood vessels were then transported back to the 
laboratory and immediately dissected free from con- 
nective tissue under a light microscope with the tis- 
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Fig. 2. A, Effect of temperature of UW solution on endothelium-independent r laxations to 
sodium nitroprusside (1 nmol/L to 100 mmol/L) at both 4 ° C (open circles) and B, 28 ° C 
(open squares) compared with Tyrode's olution at 4 ° C (closed circles) and Tyrode's at 28 ° C 
(closed squares). Relaxations to sodium nitroprusside were not affected after incubation in UW 
solution (n = 8). 
Table I. Effect of LrW solution and temperature on the potency (pD 2 values) of noradrenaline, 
5-HT, U46619, sodium nitroprusside, and acetylcholine in the human saphenous vein 
Tyrode 28 ° C Tvrode 4 ° C UW 28 ° C UW 4 ° C 
Noradrenaline 7.7 ± 0.2 7.7 +- 0.2 7.8 ± 0.3 7.7 ± 0.3 
5-HT 7.7 ± 0.2 7.7 +- 0.1 8.0 ± 0.2 7.8 ± 0.2 
U46619 9.3 + 0.1 9.2 ± 0.2 9.5 + 0.1 9.7 -+ 0.2 
SNP 6.4 ± 0.1 6.5 -+ 0.3 6.1 +- 0.2 6.3 +- 0.1 
Acetylcholine 7.0 ± 0.1 7.5 -+ 0.2 7.5 ± 0.7 7.9 ± 0.2 
SNP,  Sodium nitroprusside. 
sue emerged in Tyrode's solution at all times to 
prevent damage to the endothelium and cut into 3 to 
4 mm ring segments. The total time elapsed for 
obtaining the tissue and preparing it .for experimen- 
tation was 15 minutes. The segments were then 
placed in duplicate in plastic containers containing 
either (1) UW solution 4 ° C, (2) UW solution 
28 ° C, (3) Tyrode's solution 4 ° C, or (4) Tyrode's 
solution 28 ° C. The temperature 28 ° C (room tem- 
perature) was chosen because it is the temperature of
the solutions most commonly used to store saphe- 
nous vein conduits during the intraoperative period, 
and 4 ° C was chosen because previous studies have 
shown conflicting effects of low temperatures on en- 
dothelial cell preservation. The saphenous vein ring 
segments remained in the various storage solutions 
for 1 hour. At the end of this period the segments 
were placed into organ baths containing Tyrode's 
solution, gassed with 95% oxygen and 5% carbon 
dioxide, and kept at a constant temperature of 37 ° C. 
Gassing with a mixture ofox3,gen and carbon dioxide 
helps to maintain the pH of the solution at 7.4. 
Extreme care was taken while handling the tissues 
not to damage the endothelium during the preincu- 
bation period. Each ring segment was then stretched 
to a tension of 60 mN (optimum for maximum 
responses to 90 mmol /L  KCI), allowed to relax 
down to baseline, and then left to equilibrate for 60 
minutes. After this period each segment was chal- 
lenged twice with 90 mmol /L  KC1 to assess the 
contractile response of the tissue; the bath solution 
was changed between doses when the KCI responses 
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Fig. 3. Effect of temperature of UW solution on contrac- 
tions of human saphenous vein segments (n = 19) to 
potassium chloride (90 mmol L 1) compared with Ty- 
rode's solution (n = 20). (1 = Tyrode's 28 ° C, 2 = 
Tyrode's 4° C, 3 = UW 28 ° C, 4 = UW 4 ° C). Response 
to potassium chloride was enhanced in saphenous vein 
segments after incubation with UW solution (p < 0.001). 
reached a plateau. Two KC1 responses were per- 
formed because our previous work has shown that 
the tissue responds with a larger contraction after the 
second KCI response but that a third challenge with 
KC1 produces aplateau, indicating that the tissue is at 
its optimum tension. After the two KC1 responses the 
vessel segments were rewashed and allowed to re- 
equilibrate for another 30 minutes. After the equili- 
bration period the rings were assessed with respect to 
their ability to vasodilate or vasoconstrict in response 
to a range of vasoactive mediators. The total length 
of time for each experiment was between 6 and 8 
hours from the time of tissue harvest. 
Endothd ia l  function. To assess the effect of 
UW solution and temperature on endothelial func- 
tion, ring segments were preconstricted with 1 
nmol /L  of the thromboxane analog U46619 by 
adding the drug to the Tyrode's olution bathing the 
tissue. Once a stable plateau had been reached, cu- 
mulative additions of acetylcholine, an endothelium- 
dependent vasodilator (1 nmol /L  to 1 ~mol /L ) ,  
were made. In another set of experiments precon- 
stricted ring segments were allowed to reach a pla- 
teau, and then cumulative additions of sodium nitro- 
prusside, an endothelium-independent vasodilator 
(1 nmol /L  to 100 ~mol /L ) ,  were made. 
Smooth  muscle call function. To assess the ef- 
fect of  UW solution and temperature on smooth 
muscle fimction, vessel segments were challenged 
with either 5-HT, U46619, or noradrenaline by ad- 
dition of increasing concentrations ofeach agonist o 
the baths in a cumulative manner. On any one day 
only one vasoconstrictor was examined in the various 
groups of tissue. 
Effects o f  L -NMMA.  It has been suggested that 
UW solution has a detrimental effect on the endothe- 
lium. We have therefore examined whether a de- 
crease in nitric oxide production produced by L- 
NMMA in the saphenous vein can contribute to the 
effects of UW solution at both 4 ° C and 28 ° C by 
comparing responses with 5-HT in the saphenous 
vein. 
Analysis o f  data. The relaxations were ex- 
pressed as percentage decrease in tension of the con- 
traction induced by U46619. Contractions were 
measured as absolute tensions in millinewtons. For 
analysis of the responses the concentration of agonist 
exhibiting 50% of the maximum response (ECs0) was 
calculated. ECs0 values for each concentration-effect 
curve were obtained by linear regression analysis of  
data points versus log concentration above and be- 
low the 50% response level. The values were then 
transformed into geometric means (pD 2 values 
I - l og  ECs0]) , which were approximately normally 
distributed after analysis of frequency of values was 
performed over a range of  standard eviation units 
from the mean. All results are reported as mean + 
SEM where n = number of patients from whom the 
vessels were obtained. Statistical analysis was per- 
formed with a repeated measures analysis of variance 
followed by paired t tests with Bonferonni correction 
for multiple comparisons on each ring segment o 
address dependencies between observations at the 
same tissue and tissues from the same person. Values 
o fp  < 0.05 were considered to be statistically signif- 
icant. 
RESULTS 
Effects o f  UW solution on relaxation in the 
saphenous vein. Endothelium-dependent relax- 
ations to acetylcholine in saphenous vein segments 
were attenuated after incubation with UW solution 
was performed at both 4°C  and 28°C (Fig. 1) 
compared with control solution (Tyrode's). In con- 
trast, relaxations to the endothelium-independent 
vasodilator sodium nitroprusside were unchanged in 
the UW solution group at both temperatures (Fig. 
2). No difference in potency (pD 2 values) was seen 
between the two groups (Table I). 
Effects o f  UW solution on contractions in the 
saphenous vein. The responses to 90 mmol /L  KC1 
were enhanced in saphenous vein segments after in- 
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Fig. 4. A, Effect of temperature of UW solution on contractions of human saphenous vein 
segments o 5-HT (1 nmol/L to 10 mmol/L) at both 4 ° C (open circles) and B, 28 ° C (open 
squares) compared with Tyrode's olution at 4 ° C (closed circles) and Tyrode's at 28 ° C (closed 
squares). Contractions to 5-HT were increased after UW solution incubations (p < 0.05, n = 
7). 
cubation with UW solution (Fig. 3). Subsequent 
additions of 5-HT, noradrenaline, and U46619 all 
caused concentration-dependent contractions of  sa- 
phenous vein segments. The responses to 5-HT were 
enhanced after incubations with lAW solution at 
both 4 ° C and 28 ° C (Fig. 4). In contrast, noradren- 
aline responses in saphenous veins were enhanced 
only after incubation in lAW solution at 28 ° C com- 
pared with the response after incubations in Tyrode's 
solution (Fig. 5). The responses to low doses of  
U46619 (0.3 nmol /L  to 1 nmol /L )  were aug- 
mented after incubations of  I JW solution at 4°C  
(Fig. 6). The potency (pD2) values for each agonist 
were not significantly different after incubations in 
UW solution compared with Tyrode's olution (Ta- 
ble I). 
Effects o f  L -NMMA.  No significant difference 
was seen in the maximum developed tension to 
5-HT between L-NMMA-treated vessels and control 
vessels at both 4°C  and 28 ° C. However, vessels 
incubated with UW solution showed an increase in 
tension to 5-HT at both temperatures (Table II). 
D ISCUSSION 
This study has demonstrated that UW preserva- 
tion solution produces important selective changes in 
endothelial function and vasoreactivity of the human 
saphenous vein. These data highlight important as- 
pects of  the basic science of the saphenous vein and 
its interactions with UW solution that may be useful 
in considering the use of  U-VV solution as a preserva- 
tion solution for saphenous vein conduits. 
Our data showed that there was a decrease in 
endothelium-dependent relaxation to exogenous 
acetylcholine in isolated saphenous vein segments 
subjected to 1-hour incubation in UW solution at 
both 28°C and 4 ° C. In contrast, there was no 
attenuation of endothelium-independent r laxations 
to sodium nitroprusside after UW solution treat- 
ment. This result implies that the reduced relaxation 
to acetylcholinc was endothelium-specific, suggest- 
ing that UW solution is interfering with the nitric 
oxide-L-arginine pathway rather than directly affect- 
ing the guanylate cyclase system in the underlying 
smooth muscle cells. Previous studies have shown 
that UW solution produces temperature-dependent 
endothelial dysfunction in the isolated rat heart. 
These authors found that at more than 15 ° C UW 
solution became detrimental to coronary endothe- 
lium, but at 4°C  UW solution was found not to 
affect the coronary endothelial function} s,19 This 
result contrasts with the results reported in this 
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Fig. 5. A, Effect of temperature of UW solution on contractions of human saphenous vein 
segments o noradrenaline (1nmol/L to 10 mmol/L) at both 4 ° C (open circles) and B, 28 ° C 
(open squares) compared with Tyrode's olution at 4 ° C (closed circles) and Tyrode's at 28 ° C 
(closed squares). Contractions tonoradrenaline were increased after UW solution incubations at 
28 ° C (p < 0.05, n = 6). 
study, in which we were unable to show any differ- 
ence in temperature on the ability of UW solution to 
affect endothelium-dependent r laxations. These dis- 
crepancies may be due to the differences in the two 
models used to assess endothelium function. In the 
previous tudies the authors examined rat coronary 
artery endothelium, which may have properties dif- 
ferent from that of the human venous endothelium 
examined in this study. In addition, endothelial func- 
tion was assessed by changes in coronary flow to 
5-HT, whereas changes in isometric tension to ace- 
tylcholine were monitored in this study. Because the 
two models are different, this makes functional com- 
parisons difficult. There is evidence, however, that 
growth properties and endothelial function of hu- 
man and rat arteries are similar, 21 thus allowing cer- 
tain comparisons on endothelial function to be as- 
sessed. 
A novel finding from this study was that UW 
solution affected the responsiveness of vascular 
smooth muscle cells to a number of vasoconstrictors. 
Incubation of  saphenous vein segments with UW 
solution produced a heterogeneous responsiveness 
to 5-HT, noradrenaline, and U46619. The re- 
sponses to 5-HT were enhanced after incubation in 
UW solution at both 4 ° C and 28 ° C, whereas nor- 
adrenaline response was augmented only after incu- 
bation with UW solution at 28 ° C. U46619 re- 
sponses, on the other hand, were affected only when 
vessels were incubated in UW solution at 4 ° C. Thus 
UW solution appears to be able to alter receptor 
function, and the response may show up differently 
for different agonists depending on the temperature 
of the UW solution. Our experiments with 
L-NMMA showed that there was no potentiation of 
vasoconstrictor responses to 5-HT when the basal 
nitric oxide production was inhibited in the saphe- 
nous vein. Therefore, although our data showed an 
attenuation of acetylcholine-stimulated nitric oxide- 
dependent relaxation after incubation with UW solu- 
tion, this was not a factor in the potentiation of 
vasoconstrictor responses to 5-HT. The reason for 
this result may be that the saphenous vein produces 
minimal basal nitric oxide under normal conditions. 
The role of  prostacyclin was not examined in this 
study, and therefore it is not known at this time 
whether inhibition of prostacyclin or a combined 
inhibition with nitric oxide could have contributed 
to the increased responsiveness of the saphenous vein 
to the agonists tested. 
The contractions produced by potassium chlo- 
ride in saphenous veins were also augmented after 
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Fig. 6. A, Effect of temperature of UW solution on contractions of human saphenous vein 
segments o U46619 (0.1 nmol/L to 1 retool/L) at both 4 ° C (open circles) and B, 28 ° C (open 
squares) compared with Tyrode's olution at 4 ° C (closed circles) and Tyrode's at 28 ° C (closed 
squares). Contractions to U46619 (0.3 nmol/L to 1 nmol/L) were increased after UW 
solution incubations at 4 ° C (p < 0.05, n = 7). 
UW solution treatment. This result suggests that 
UW solution has an enhancing effect on the complex 
sequence of events leading from depolarization of 
the cell membrane to activation of the contractile 
processes in smooth muscle cells. Thus the response 
of the saphenous vein smooth muscle cells to UW 
solution at different emperatures may be manifested 
either by subtle changes at a particular receptor or by 
a common effect that ultimately enhances the 
smooth muscle contractile machinery. 
The mechanism responsible for the attenuation 
of  endothelium-dependent relaxations i likely to be 
the composition of UW solution. UW solution is an 
intracellular type solution with a potassium concen- 
tration of  125 mmol /L  and a sodium concentration 
of  20 mmol /L ,  and it contains various additives. 22 
Potassium in excess of 30 mmol /L  is known to cause 
endothelial dysfunction./s The cytotoxicity of vari- 
ous hyperkalemic rystalloid cardioplegic solutions 
has been demonstrated with a tissue culture tech- 
nique. 14 In another study a high concentration of 
potassium has been shown to cause functional zs and 
morphologic 26 damage to coronary vascular endo- 
thelium. Therefore it is possible that the UW solu- 
tion is affecting endothelial function by virtue of its 
high potassium content. The reasons for the aug- 
mented smooth muscle responses are not known. 
Table I I .  Comparison of the effects of 
L-NMMA, UW solution, and Tyrode's 
solution at different emperatures on 
5-HT-induced maximum responses (Emax) in 
the saphenous vein 
E~,~ values 
28 ° C 4 ° C 
5-HT 50.3  -+ 9.4  45.8  + 10.4 
UW Sol 64.3  _+ 15.4 69 .9  + 21 
L -NMMA 57.4  + 9.0 41 .4  -+ 10.4 
However, these responses could be due to a complex 
ionic interaction among sodium, potassium, and cal- 
cium at the smooth muscle cell membrane. For ex- 
ample, high-potassium-induced depolarization may 
activate calcium channels, allowing the intracellular 
calcium to rise and therefore become available for 
smooth muscle cell contraction. 
It  is important o evaluate UW solution under 
different conditions and with different models of en- 
dothelial cell function to evaluate its potential use as 
a preservation solution for saphenous veins. In this 
context the clinical implications of  these findings 
discourage the use of UW solution for preservation 
of saphenous vein conduits. The reasons are as fol- 
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lows. A diminished stimulated release of nitric oxide 
in the postoperative period together with an en- 
hanced responsiveness to vasoconstrictor stimuli in- 
cluding 5-HT and TxA2, which can be produced by 
platelets adhering to the endothelium and noradren- 
aline that may be given during the perioperative 
period, could produce vasospasm of the saphenous 
vein conduits and therefore have a detrimental affect 
on perfusion. In addition, nitric oxide is known to 
inhibit smooth muscle cell proliferation and platelet 
adhesion, 27 and therefore a loss of  nitric oxide could 
also contribute to intimal proliferation after the graft 
is inserted. 
One of the major limitations of our studies is 
trying to equate the impact of  the findings of a 
relatively short-term in vitro experiment to what hap- 
pens to the conduits in the long-term. There is, 
however, evidence to suggest that even short-term 
effects on endothelial and smooth muscle cell func- 
tion are long-lasting 2s-31 and could result in influenc- 
ing the course of graft function. 
In summary, this study has shown specific poten- 
tially detrimental effects of UW solution on endothe- 
lial and smooth muscle function of isolated human 
saphenous vein. Further studies are required to un- 
derstand the complex interactions between the dif- 
ferent components of UW solution and its possible 
effects on the performance of the saphenous vein as a 
bypass graft. 
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